Literature DB >> 25620732

Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.

Maxim Polonsky1, Lyuba Azbel2, Jeffrey A Wickersham3, Faye S Taxman4, Evgeny Grishaev5, Sergey Dvoryak5, Frederick L Altice6.   

Abstract

BACKGROUND: Ukraine is experiencing one of the most volatile HIV epidemics globally, fueled primarily by people who inject drugs (PWIDs), and a parallel incarceration epidemic. Opioid substitution therapy (OST) is internationally recognized as one of the most effective forms of treatment for opioid dependence and is among the most effective HIV prevention strategies available, yet efforts to adopt it in Ukraine's Criminal Justice System (CJS) have been thwarted.
METHODS: To understand the reluctance of the Ukrainian CJS to adopt OST despite the overwhelming evidence pointing to its health benefits and improved criminal justice outcomes, we conducted the first survey of Ukrainian prison administrative, medical and custodial staff (N=243) attitudes towards addiction in general, OST, and people living with HIV/AIDS (PLWHA) in representative regions of Ukraine.
RESULTS: Results revealed that Ukrainian CJS workers' attitudes toward OST, PLWHA, and drug addiction were universally negative, but differed substantially along geographic and occupational lines. Whereas geographic and cultural proximity to the European Union drove positive attitudes in the west, in the southern region we observed an identifiability effect, as workers who worked directly with prisoners held the most positive attitudes. We also found that knowledge mediated the effect of drug intolerance on OST attitudes.
CONCLUSION: In Ukraine, adoption of OST is more influenced by myths, biases and ideological prejudices than by existing scientific evidence. By elucidating existing attitudes among CJS personnel, this study will help to direct subsequent interventions to address the barriers to implementing evidence-based HIV prevention treatments.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Attitudes; HIV/AIDS; Healthcare providers; Methadone; Opioid substitution therapy; Ukraine

Mesh:

Year:  2014        PMID: 25620732      PMCID: PMC4330127          DOI: 10.1016/j.drugalcdep.2014.12.008

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  60 in total

Review 1.  Equivalence of the mediation, confounding and suppression effect.

Authors:  D P MacKinnon; J L Krull; C M Lockwood
Journal:  Prev Sci       Date:  2000-12

2.  Mediation in experimental and nonexperimental studies: new procedures and recommendations.

Authors:  Patrick E Shrout; Niall Bolger
Journal:  Psychol Methods       Date:  2002-12

3.  No opiate substitutes for the masses of IDUs.

Authors:  Jon Cohen
Journal:  Science       Date:  2010-07-09       Impact factor: 47.728

4.  Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.

Authors:  Sasha Uhlmann; M-J Milloy; Thomas Kerr; Ruth Zhang; Silvia Guillemi; David Marsh; Robert S Hogg; Julio S G Montaner; Evan Wood
Journal:  Addiction       Date:  2010-03-10       Impact factor: 6.526

5.  Retention in naltrexone implant treatment for opioid dependence.

Authors:  Nikolaj Kunøe; Philipp Lobmaier; John Kåre Vederhus; Bjørg Hjerkinn; Solfrid Hegstad; Michael Gossop; Oistein Kristensen; Helge Waal
Journal:  Drug Alcohol Depend       Date:  2010-05-31       Impact factor: 4.492

Review 6.  An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research.

Authors:  Laura Amato; Marina Davoli; Carlo A Perucci; Marica Ferri; Fabrizio Faggiano; Richard P Mattick
Journal:  J Subst Abuse Treat       Date:  2005-06

7.  Naltrexone implants compared to methadone: outcomes six months after prison release.

Authors:  Philipp P Lobmaier; Nikolaj Kunøe; Michael Gossop; Tormod Katevoll; Helge Waal
Journal:  Eur Addict Res       Date:  2010-04-26       Impact factor: 3.015

Review 8.  Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.

Authors:  Frederick L Altice; Adeeba Kamarulzaman; Vincent V Soriano; Mauro Schechter; Gerald H Friedland
Journal:  Lancet       Date:  2010-07-31       Impact factor: 79.321

Review 9.  Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.

Authors:  Daniel Wolfe; M Patrizia Carrieri; Donald Shepard
Journal:  Lancet       Date:  2010-07-31       Impact factor: 79.321

10.  Next steps for Ukraine abolition of HIV registries, implementation of routine human immunodeficiency virus testing and expansion of services.

Authors:  Jacob M Izenberg; Frederick L Altice
Journal:  Addiction       Date:  2010-03       Impact factor: 6.526

View more
  20 in total

1.  Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine.

Authors:  Ruthanne Marcus; Iuliia Makarenko; Alyona Mazhnaya; Alexei Zelenev; Maxim Polonsky; Lynn Madden; Sergii Filippovych; Sergii Dvoriak; Sandra A Springer; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2017-08-05       Impact factor: 4.492

2.  Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic.

Authors:  Kostyantyn Dumchev; Sergii Dvoryak; Olena Chernova; Olga Morozova; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2017-08-08

3.  Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.

Authors:  Iuliia Makarenko; Alyona Mazhnaya; Ruthanne Marcus; Martha J Bojko; Lynn Madden; Sergii Filippovich; Sergii Dvoriak; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2017-06-16

4.  Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators.

Authors:  Maxim Polonsky; Julia Rozanova; Lyuba Azbel; Chethan Bachireddy; Jacob Izenberg; Tetiana Kiriazova; Sergii Dvoryak; Frederick L Altice
Journal:  AIDS Behav       Date:  2016-12

5.  Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.

Authors:  Olga Morozova; Sergey Dvoriak; Iryna Pykalo; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2017-02-21       Impact factor: 4.492

6.  Perceptions of Health-Related Community Reentry Challenges among Incarcerated Drug Users in Azerbaijan, Kyrgyzstan, and Ukraine.

Authors:  Julia Rozanova; Olga Morozova; Lyuba Azbel; Chethan Bachireddy; Jacob M Izenberg; Tetiana Kiriazova; Sergiy Dvoryak; Frederick L Altice
Journal:  J Urban Health       Date:  2018-08       Impact factor: 3.671

7.  Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting.

Authors:  Jeffrey A Lam; Hye In Sarah Lee; Ashley Q Truong; Alexandria Macmadu; Jennifer G Clarke; Josiah Rich; Brad Brockmann
Journal:  J Subst Abuse Treat       Date:  2019-06-10

8.  In Their Own Voices: Breaking the Vicious Cycle of Addiction, Treatment and Criminal Justice Among People who Inject Drugs in Ukraine.

Authors:  Alyona Mazhnaya; Martha J Bojko; Ruthanne Marcus; Sergii Filippovych; Zahedsul Islam; Sergey Dvoriak; Frederick L Altice
Journal:  Drugs (Abingdon Engl)       Date:  2016-02-16

9.  Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.

Authors:  Trena I Mukherjee; Jeffrey A Wickersham; Mayur M Desai; Veena Pillai; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2016-05-09       Impact factor: 4.492

10.  Accessing methadone within Moldovan prisons: Prejudice and myths amplified by peers.

Authors:  Maxim Polonsky; Lyuba Azbel; Jeffrey A Wickersham; Ruthanne Marcus; Svetlana Doltu; Evgeny Grishaev; Sergey Dvoryak; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2015-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.